We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Proteros and SUPERGEN Enter Into an Integrated Lead Discovery Agreement

News   Feb 04, 2011

 
Proteros and SUPERGEN Enter Into an Integrated Lead Discovery Agreement
 
 
 

RELATED ARTICLES

Enhancing the Infection-fighting Potential of Natural Products

News

A team has identified multiple promising new drug candidates to treat antibiotic-resistant infections, including the superbug MRSA.

READ MORE

Researchers Combat Drug-resistant Tuberculosis in the Lab

News

Scientists have found a way to reverse drug-resistant tuberculosis in the lab.

READ MORE

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

News

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE